24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Nucleai
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:38
Who will cover the damages of the largest computer failure in history?
16:00
Scopio Labs secures $42 million Series D for AI-based blood cell analysis
14:47
"Growing high-tech is essential for the economy of the North"
14:31
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
2
JPMorgan CEO Jamie Dimon makes whirlwind visit to Israel
3
From IPO dreams to CrowdStrike’s crisis: Inside the collapse of the Wiz-Google mega deal
4
Israel’s Quantum Transistors receives €17.5M from the European Innovation Council for its quantum computing solution
5
Amdocs set to cut 1,500-3,000 jobs in new round of layoffs
More news
Nucleai
6 stories about Nucleai
Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm
03.04.24
|
CTech
Leveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types
How have international stakeholders responded to Startup Nation since 7/10?
26.10.23
|
James Spiro
Nucleai helped its global customers and investors understand the magnitude of October 7 by comparing it to 9/11 in the U.S.
Nucleai raises $33 million for spatial biology drug development platform
22.03.22
|
Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
The Israeli startup using spatial biology to provide better cancer treatment
02.01.22
|
Yafit Ovadia
Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions
AI cancer treatment startup Nucleai raises $6.5 million in series A round
07.07.20
|
Meir Orbach
Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment
CTech’s Monday Israeli Tech News Roundup
05.03.18
|
CTech
Israel wants to lure U.S. scientists with $100 thousand grants. Barclays ends partnership with Ness Technologies
Please ensure Javascript is enabled for purposes of
website accessibility